Literature DB >> 1265442

Serum lysozyme in Crohn's disease and ulcerative colitis.

E Hylander, N E Hansen, H Karle, S Janrum.   

Abstract

Serum lysozyme (muramidase) was determined in 72 patients with Crohn's disease or ulcerative colitis. Serum lysozyme was elevated in both disease groups. The mean enzyme level was significantly higher in Crohn's disease than in ulcerative colitis, but there was a considerable overlapping between the groups, which makes serum lysozyme determination of dubious value in the differential diagnosis between Crohn's disease and ulcerative colitis. No correlation was found between the serum lysozyme concentration and the activity of the diseases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1265442

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Crohn disease. Newer aspects of etiology, diagnosis and therapy.

Authors: 
Journal:  West J Med       Date:  1978-05

2.  Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease.

Authors:  O S El-Khatib; O Lebwohl; A A Attia; C A Flood; J A Stein; J G Sweeting; R T Whitlock; E F Osserman; P R Holt
Journal:  Am J Dig Dis       Date:  1978-04

3.  Serum and tissue lysozyme in leprosy.

Authors:  T H Rea; C R Taylor
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Serum and faecal lysozyme in inflammatory bowel disease.

Authors:  H J Klass; G Neale
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

5.  Factors in the management of Crohn's disease: a discussion paper.

Authors:  W T Cooke
Journal:  J R Soc Med       Date:  1981-10       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.